Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
MDL Judge Dismisses Four Paraquat Bellwether Cases, After Excluding Plaintiffs’ Expert Witness From Testifying at Trial The Court determined that there were deficiencies in the experts determination that there is a causal link between Paraquat and Parkinson’s disease, rendering the testimony insufficiently reliable to allow a jury to consider it at trial. April 18, 2024 Irvin Jackson Add Your Comments The U.S. District Judge presiding over all Paraquat Parkinson’s disease lawsuits has excluded a key expert witness from testifying at trial, leaving four individual bellwether cases without the required support to move forward to trial. The cases are part of a massive litigation being pursued against Syngenta and Chevron, which currently includes more than 5,000 lawsuits claiming that exposure to the toxic herbicide Paraquat caused Parkinson’s disease. Each of the claims raise similar allegations that the manufacturers failed to adequately warn users about the risks associated with spraying, mixing, transporting or otherwise coming into contact with the controversial weed killer. In support of their claims, plaintiffs have proposed a collection of expert witnesses, which will testify about the link between Paraquat and Parkinson’s, pointing to research they believe shows that exposure to the toxic herbicide may cause the progressive neurological disease. However, the manufacturers have maintained that their product is safe, and dispute the conclusions reached by many of the experts. PARAQUAT Parkinson’s Lawsuits Were you or a loved one exposed to Paraquat? Lawyers are reviewing Paraquat lawsuits for individuals who were exposed to Paraquat and developed Parkinson’s disease. Learn More SEE IF YOU QUALIFY FOR COMPENSATION PARAQUAT Parkinson’s Lawsuits Were you or a loved one exposed to Paraquat? Lawyers are reviewing Paraquat lawsuits for individuals who were exposed to Paraquat and developed Parkinson’s disease. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Given common questions of fact and law raised in complaints brought by individuals nationwide, all federal Paraquat lawsuits are centralized before U.S. District Judge Nancy J. Rosenstengel in the Southern District of Illinois, as part of a federal MDL, or multidistrict litigation. As part of the coordinated management of the litigation Judge Rosenstengel established a bellwether process, where a small group of cases have been prepared for a series of early trial dates. While the outcome of these bellwether cases does not have any binding impact on other plaintiffs, they are designed to help gauge how the court and juries may respond to certain evidence and testimony that may be repeated throughout thousands of individual claims. Causation Expert in Paraquat Bellwether Trial Cases Dismissed Last year, Judge Rosenstengel held Paraquat “Daubert” hearings, during which the Court considered the admissibility of proposed expert testimony in the early bellwether cases, to gauge whether the opinions offered were based on sufficiently sound and reliable science to allow a jury to consider the evidence under federal rules. Following those hearings, defendants filed a motion calling for the exclusion of the expert testimony of Dr. Martin Wells, an epidemiologist and statistician from Cornell University, whose testimony was the key to establishing causation in at least four of the bellwether cases. In a memorandum and order (PDF) issued on April 17, Judge Rosenstengel sided with defendants, declaring that Wells’ expert testimony should be excluded due to deficiencies in his determination that Paraquat has a causal link to Parkinson’s disease. As Wells was the only plaintiffs’ expert witness to establish that Paraquat caused their injuries, all four of the bellwether trials were dismissed in another court order (PDF) issued that same day. Next Steps in Paraquat Lawsuits in 2024 Following the dismissal of the initial four Paraquat bellwether cases, Judge Rosenstengel indicates that the court will move forward with a second group of claims that will go through case-specific workup, which may involve different expert testimony. “Considering the dismissal of the four trial selection cases, the Court intends to expeditiously identify a new set of trial cases and set a tight schedule for limited discovery and trial,” Judge Rosenstengel wrote. “To that end, the Parties are DIRECTED to select 16 member cases for limited fact discovery on or before Friday, May 10, 2024.” The order calls for plaintiffs to select eight cases, and Syngenta and Chevron to select four each for potential bellwether trials. Similar to the first bellwether pool, it is likely those selections will later be narrowed down to a smaller group that will go through expert discovery and full work up for trial. The outcome of this ruling on the future of the Paraquat litigation is not currently known, but a number of lawyers have indicated that their cases rely on different expert witness testimony, which utilized different methods to establish the link between Paraquat and Parkinson’s disease. In addition, a large number of Paraquat cases are currently pending in various different state courts, which have different evidentiary standards for the admissibility of expert witness testimony. Therefore, unless Syngenta and Chevron are able to negotiate a global Paraquat settlement agreement in the wake of this recent ruling, they will continue to face litigation over the warnings previously provided to users of the herbicide. Tags: Chevron, Herbicide, Paraquat, Parkinsons Disease, Syngenta, Weed Killer Image Credit: | Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. More Paraquat Lawsuit Stories Paraquat MDL Lawsuit Deadlines Extended Again, as Settlement Details Finalized August 12, 2025 Paraquat Parkinson’s Disease Settlement Terms Still Being Finalized June 30, 2025 MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 May 16, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Woman Will Need Lifelong Monitoring After Depo-Provera Brain Tumor: Lawsuit (Posted: today) A Depo-Provera brain tumor lawsuit indicates an Ohio woman must undergo medical scans for the rest of her life after having a surgery to remove a meningioma. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Brain Tumor Caused Numbness Over Half of Woman’s Body, Lawsuit Alleges (08/01/2025)Depo-Provera MDL Judge Pushes for Meningioma Lawsuits To Be Filed Quicker (07/25/2025)Depo-Provera Meningioma Diagnosis Resulted in Invasive Brain Surgery, Lawsuit Alleges (07/21/2025) Lawsuit Claims Cartiva Implant Caused Bone Loss and Nerve Damage in Big Toe (Posted: yesterday) A Cartiva implant lawsuit blames the manufacturer for failing to warn patients about high failure rates for years after it began receiving implant complication reports. MORE ABOUT: CARTIVA IMPLANT LAWSUITJudge Orders Cartiva Implant Settlement Talks Before Trial in Aug. 2026 (07/28/2025)Cartiva Settlement Rumors Mount Again, as More Toe Implant Lawsuits Withdrawn and Trials Approach (06/26/2025)Failed Cartiva Implant Resulted in Need for Removal, Big Toe Fusion Surgery: Lawsuit (04/10/2025) Nearly 200 Women Pursuing BioZorb Lawsuits Over Complications With Breast Tissue Marker (Posted: 2 days ago) Hologic faces at least 183 BioZorb lawsuits, a number which continues to grow as the first bellwether trial is pushed back to January 2026. MORE ABOUT: BIOZORB LAWSUITFailed BioZorb Tissue Marker to Require Surgical Removal, Lawsuit Claims (08/04/2025)Problems With BioZorb Tissue Markers Not Adequately Disclosed by Manufacturer: Lawsuit (07/28/2025)Lawyers Preparing BioZorb Lawsuit To Go Before Jury on Sept. 8, 2025 (07/23/2025)
Woman Will Need Lifelong Monitoring After Depo-Provera Brain Tumor: Lawsuit (Posted: today) A Depo-Provera brain tumor lawsuit indicates an Ohio woman must undergo medical scans for the rest of her life after having a surgery to remove a meningioma. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Brain Tumor Caused Numbness Over Half of Woman’s Body, Lawsuit Alleges (08/01/2025)Depo-Provera MDL Judge Pushes for Meningioma Lawsuits To Be Filed Quicker (07/25/2025)Depo-Provera Meningioma Diagnosis Resulted in Invasive Brain Surgery, Lawsuit Alleges (07/21/2025)
Lawsuit Claims Cartiva Implant Caused Bone Loss and Nerve Damage in Big Toe (Posted: yesterday) A Cartiva implant lawsuit blames the manufacturer for failing to warn patients about high failure rates for years after it began receiving implant complication reports. MORE ABOUT: CARTIVA IMPLANT LAWSUITJudge Orders Cartiva Implant Settlement Talks Before Trial in Aug. 2026 (07/28/2025)Cartiva Settlement Rumors Mount Again, as More Toe Implant Lawsuits Withdrawn and Trials Approach (06/26/2025)Failed Cartiva Implant Resulted in Need for Removal, Big Toe Fusion Surgery: Lawsuit (04/10/2025)
Nearly 200 Women Pursuing BioZorb Lawsuits Over Complications With Breast Tissue Marker (Posted: 2 days ago) Hologic faces at least 183 BioZorb lawsuits, a number which continues to grow as the first bellwether trial is pushed back to January 2026. MORE ABOUT: BIOZORB LAWSUITFailed BioZorb Tissue Marker to Require Surgical Removal, Lawsuit Claims (08/04/2025)Problems With BioZorb Tissue Markers Not Adequately Disclosed by Manufacturer: Lawsuit (07/28/2025)Lawyers Preparing BioZorb Lawsuit To Go Before Jury on Sept. 8, 2025 (07/23/2025)